C-reactive Protein, Body Mass Index, and Diabetic Retinopathy
Open Access
- 1 September 2010
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 51 (9) , 4458-4463
Abstract
Purpose.: C-reactive protein (CRP) is an inflammatory biomarker that may be associated with diabetic retinopathy (DR), but body mass index (BMI) is an important confounder of this relationship. The purpose of this study was to determine the relationship between CRP, BMI, and existing DR. Methods.: This was a population-based, cross-sectional study on 718 persons with diabetes in the Singapore Malay Eye Study (SiMES). Diabetes was defined as random glucose ≥ 11.1 mmol/L, on diabetic medication or a history of physician-diagnosed diabetes. CRP was measured in frozen plasma. DR was graded from retinal photographs. Results.: Higher CRP and BMI were associated with lower prevalence of DR. After adjustment for age, sex, HbA1c level, hypertension, smoking, total cholesterol level, cholesterol-lowering medication, and insulin use, persons with the highest quartiles of CRP were less likely to have any DR (odds ratio [OR] 0.5; 95% CI, 0.3–0.9, comparing the fourth with the first quartile of CRP), vision-threatening DR (OR 0.3; 95% CI, 0.1–0.7), or CSME (OR 0.2; 95% CI, 0.1–0.6). Similarly, persons with the highest quartiles of BMI were less likely to have any DR (OR 0.5; 95% CI, 0.3–0.7), moderate DR (OR 0.4; 95% CI, 0.2–0.7), vision-threatening DR (OR 0.4; 95% CI, 0.1–0.8) or CSME (OR 0.2; 95% CI, 0.0–1.0). No significant interactions between CRP and BMI on DR were seen. Conclusions.: Persons with diabetes who had higher levels of CRP and BMI were less likely to have DR. Further research is needed to understand the interrelationship role of inflammation, body weight, and microvascular complications.Keywords
This publication has 36 references indexed in Scilit:
- Abdominal Adiposity Is Associated With Elevated C-Reactive Protein Independent of BMI in Healthy Nonobese PeopleDiabetes Care, 2009
- Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic RetinopathyDiabetes Care, 2009
- Glitazone Use Associated with Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2009
- Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay eye studyEye, 2008
- Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in DelhiSleep Medicine, 2008
- C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor α, on human monocytesThrombosis and Haemostasis, 2008
- Obesity and Eye DiseasesSurvey of Ophthalmology, 2007
- Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye StudyEye, 2007
- Associations between the Metabolic Syndrome and Retinal Microvascular Signs: The Atherosclerosis Risk in Communities StudyInvestigative Ophthalmology & Visual Science, 2004
- Endothelium-Dependent and -Independent Vasodilation of Large Arteries in Normoalbuminuric Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1996